Roberts F, Calcutt C R
Neuroscience. 1983 Aug;9(4):721-39. doi: 10.1016/0306-4522(83)90264-6.
The chemical tools that could be used to examine the function of histamine in the brain are considered together with the evidence linking histamine specifically with the hypothalamus. The distribution of histamine and the enzymes responsible for its synthesis and metabolism is consistent with there being both mast cells and histaminergic nerve terminals within the hypothalamus. Iontophoresis, mepyramine binding and histamine-stimulated adenylate cyclase studies suggest that both histamine H1- and H2- receptors are present in the hypothalamus. In addition, intracerebroventricularly injected histamine receptor agonists and antagonists affect many functions associated with the hypothalamus such as cardiovascular control, food intake, body temperature control, and pituitary hormones whose release is mediated via the hypothalamus, such as corticotropin, growth hormone, thyroid stimulating hormone, prolactin, gonadotropins and vasopressin. However, only in the case of thyroliberin release, prolactin release, body fluid control and blood pressure control is there evidence yet that such effects are mediated via histamine receptors actually in the hypothalamus. The effects of enzyme inhibitors suggest endogenous histamine may be involved in the physiological control of thyroid stimulating hormone, growth hormone and blood pressure, and the effects of receptor antagonists support a role for endogenous histamine in prolactin control. Otherwise, there is little evidence for a physiological role for endogenous, as against exogenous, histamine whether it be from histaminergic terminals or mast cells. In addition, few studies have tried to distinguish possible effects on presynaptic receptors, postsynaptic receptors, hypothalamic blood vessels or the hypophyseal portal blood vessels. It is concluded that although there is good evidence now linking histamine and the hypothalamus more specific studies are required, for instance using microinjection or in vitro techniques and the more specific chemical tools now available, to enable a clearer understanding of the physiological role of histamine in the hypothalamus.
可用于研究组胺在大脑中功能的化学工具,与将组胺特别与下丘脑联系起来的证据一同被考量。组胺及其合成与代谢相关酶的分布,与下丘脑内同时存在肥大细胞和组胺能神经末梢相一致。离子导入法、美吡拉敏结合以及组胺刺激的腺苷酸环化酶研究表明,下丘脑同时存在组胺H1和H2受体。此外,脑室内注射组胺受体激动剂和拮抗剂会影响许多与下丘脑相关的功能,如心血管控制、食物摄入、体温调节,以及其释放经由下丘脑介导的垂体激素,如促肾上腺皮质激素、生长激素、促甲状腺激素、催乳素、促性腺激素和血管加压素。然而,只有在促甲状腺激素释放、催乳素释放、体液控制和血压控制方面,才有证据表明这些作用实际上是通过下丘脑内的组胺受体介导的。酶抑制剂的作用表明内源性组胺可能参与促甲状腺激素、生长激素和血压的生理控制,而受体拮抗剂的作用支持内源性组胺在催乳素控制中的作用。否则,几乎没有证据表明内源性组胺(与外源性组胺相对)无论是来自组胺能神经末梢还是肥大细胞具有生理作用。此外,很少有研究试图区分对突触前受体、突触后受体、下丘脑血管或垂体门脉血管可能产生的影响。得出的结论是,尽管现在有充分证据将组胺与下丘脑联系起来,但仍需要更具体的研究,例如使用显微注射或体外技术以及现有的更具特异性的化学工具,以便更清楚地了解组胺在下丘脑中的生理作用。